What is SynBioBeta?
SynBioBeta operates as a premier global nexus for the synthetic biology industry, bridging the gap between biological engineers, venture capitalists, and corporate innovators. By curating high-impact events and providing deep-dive industry intelligence, the company facilitates the commercialization of biological technologies. Its market position is defined by its ability to aggregate stakeholders across the biotechnology and healthcare sectors, effectively serving as a catalyst for cross-disciplinary collaboration and knowledge exchange in an increasingly complex regulatory and scientific landscape.
How much funding has SynBioBeta raised?
SynBioBeta has raised a total of $120K across 1 funding round:
Debt
$120K
Debt (2021): $120K with participation from PPP
Key Investors in SynBioBeta
PPP
Public-Private Partnership
What's next for SynBioBeta?
With this recent capital deployment, SynBioBeta is poised to scale its operational footprint ahead of its flagship 2026 conference. The strategic focus will likely shift toward expanding its digital intelligence platform and enhancing its networking infrastructure to accommodate the rapid influx of new market entrants. By leveraging this financial backing, the company aims to deepen its influence within the global bio-economy, ensuring that its community remains at the forefront of the engineering biology revolution while navigating the challenges of a rapidly evolving technological market.
See full SynBioBeta company page
